Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 10
pubmed:dateCreated
2002-9-18
pubmed:abstractText
Vaccinia virus (VV) infection produces several types of virus particle called intracellular mature virus (IMV), intracellular enveloped virus (IEV), cell-associated enveloped virus (CEV) and extracellular enveloped virus (EEV). Some cellular antigens are associated with EEV and these vary with the cell type used to grow the virus. To investigate if specific cell antigens are associated with VV particles, and to address the origin of membranes used to envelope IMV and IEV/CEV/EEV, we have studied whether cell antigens and foreign antigens expressed by recombinant VVs are incorporated into VV particles. Membrane proteins that are incorporated into the endoplasmic reticulum (ER), intermediate compartment (IC), cis/medial-Golgi, trans-Golgi network (TGN) or plasma membrane were not detected in purified IMV particles. In contrast, proteins present in the TGN or membrane compartments further downstream in the exocytic pathway co-purify with EEV particles when analysed by immunoblotting. Immunoelectron microscopy found only low levels of these proteins in IEV, CEV/EEV. The incorporation of foreign antigens into VV particles was not affected by loss of individual IEV or EEV-specific proteins or by redirection of B5R to the ER. These data suggest that (i) host cell antigens are excluded from the lipid envelope surrounding the IMV particle and (ii) membranes of the ER, IC and cis/medial-Golgi are not used to wrap IMV particles to form IEV. Lastly, the VV haemagglutinin was absent from one-third of IEV and CEV/EEV particles, whereas other EEV antigens were present in all these virions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/42kDa protein, Vaccinia virus, http://linkedlifedata.com/resource/pubmed/chemical/A33R protein, Vaccinia virus, http://linkedlifedata.com/resource/pubmed/chemical/A34R protein, Vaccina virus, http://linkedlifedata.com/resource/pubmed/chemical/A36R protein, Vaccinia virus, http://linkedlifedata.com/resource/pubmed/chemical/A56R protein, Orthopoxvirus, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD29, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD46, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD55, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD59, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD81, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation..., http://linkedlifedata.com/resource/pubmed/chemical/CD46 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CD71 antigen, http://linkedlifedata.com/resource/pubmed/chemical/CD81 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CKAP4 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Hemagglutinins, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transferrin, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/Viral Envelope Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Viral Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Viral Structural Proteins, http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Microglobulin, http://linkedlifedata.com/resource/pubmed/chemical/macrogolgin
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-1317
pubmed:author
pubmed:issnType
Print
pubmed:volume
83
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2347-59
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:12237415-Animals, pubmed-meshheading:12237415-Antigens, CD, pubmed-meshheading:12237415-Antigens, CD29, pubmed-meshheading:12237415-Antigens, CD46, pubmed-meshheading:12237415-Antigens, CD55, pubmed-meshheading:12237415-Antigens, CD59, pubmed-meshheading:12237415-Antigens, CD81, pubmed-meshheading:12237415-Antigens, Differentiation, B-Lymphocyte, pubmed-meshheading:12237415-Cell Line, pubmed-meshheading:12237415-Cercopithecus aethiops, pubmed-meshheading:12237415-Endoplasmic Reticulum, pubmed-meshheading:12237415-Glycoproteins, pubmed-meshheading:12237415-HeLa Cells, pubmed-meshheading:12237415-Hemagglutinins, Viral, pubmed-meshheading:12237415-Histocompatibility Antigens Class I, pubmed-meshheading:12237415-Humans, pubmed-meshheading:12237415-Membrane Glycoproteins, pubmed-meshheading:12237415-Membrane Proteins, pubmed-meshheading:12237415-Microscopy, Immunoelectron, pubmed-meshheading:12237415-Receptors, Transferrin, pubmed-meshheading:12237415-Tumor Suppressor Protein p53, pubmed-meshheading:12237415-Vaccinia virus, pubmed-meshheading:12237415-Viral Envelope Proteins, pubmed-meshheading:12237415-Viral Proteins, pubmed-meshheading:12237415-Viral Structural Proteins, pubmed-meshheading:12237415-Virion, pubmed-meshheading:12237415-beta 2-Microglobulin
pubmed:year
2002
pubmed:articleTitle
An investigation of incorporation of cellular antigens into vaccinia virus particles.
pubmed:affiliation
Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't